Who is sponsoring NCT02862691?

NCT02862691 is sponsored by Stony Brook University.

What drugs are being tested in NCT02862691?

Interventions in NCT02862691: Acetaminophen/Oxycodone (Oral analgesic), Bupivicaine (Injectable local anesthetic).

Is NCT02862691 still recruiting?

NCT02862691 is currently terminated. Last updated 25 April 2018.

Last reviewed 2018-04-25 · How we verify

NCT02862691

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Percocet vs. Bupivicaine for Toothaches in the ED

Terminated Phase 2 Last updated 25 April 2018

What this trial tests

Phase 2 trial testing Acetaminophen/Oxycodone (Oral analgesic) in Toothache in 2 participants. Terminated before completion.

Timeline

1 August 2016

Primary endpoint
1 August 2017

1 August 2017

Quick facts

Lead sponsor	Stony Brook University
Phase	Phase 2
Status	Terminated
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	none
Primary purpose	treatment
Enrollment	2
Start date	1 August 2016
Primary completion	1 August 2017
Estimated completion	1 August 2017
Sites	1 location across United States

Drugs / interventions tested

Acetaminophen/Oxycodone (Oral analgesic) — full drug profile →
Bupivicaine (Injectable local anesthetic) — full drug profile →

Conditions studied

Toothache — all drugs for Toothache →

Sponsor

Stony Brook University

Who can join

18 and older, any sex, with Toothache. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The goal of this study is to compare the speed and adequacy of pain relief in Emergency Department patients with a toothache after an oral analgesic or a local anesthetic administered as a nerve block or by local infiltration.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other Stony Brook University trials

Trials by the same sponsor.

NCT07478250 — First Responder Safety Training (FiRST) · NA · not yet recruiting
NCT07076342 — The Role of mGluR5 in CBT-I · Phase 4 · recruiting
NCT07009691 — Hydrogen Water Intervention With Heart Rate Variability as an Outcome Biomarker in ME/CFS · NA · recruiting
NCT07114900 — Randomized Controlled Physical Activity App Intervention for Black Women · Phase 3 · active not recruiting
NCT05245227 — Double Simultaneous Uterotonic Agents Versus Single Agent Regimen to Prevent Early Postpartum Hemorrhage · Phase 3 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT02862691 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Stony Brook University
Last refreshed: 25 April 2018

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT02862691.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing